The structure-activity relationship of inhibitors of serotonin uptake and receptor binding

SummaryAn analysis of five different datasets of inhibitors of serotonin uptake has yielded quantitative structure/ activity relationships (QSARs) which delineate the role of steric and hydrophobic properties essential for inhibition by phenylethylamine-type analogues.

[1]  Y. Martin,et al.  Quantitative drug design , 1978 .

[2]  Albert J. Leo,et al.  The octanol–water partition coefficient of aromatic solutes: the effect of electronic interactions, alkyl chains, hydrogen bonds, and ortho-substitution , 1983 .

[3]  C. Hansch,et al.  Structure-activity relationships of antineoplastic agents in multidrug resistance. , 1990, Journal of medicinal chemistry.

[4]  J. Topliss.  Quantitative structure-activity relationships of drugs , 1983 .

[5]  C. Hansch,et al.  Molecular graphics and QSAR in the study of enzyme-ligand interactions. On the definition of bioreceptors , 1986 .

[6]  G. Jolles,et al.  Drug design : fact or fantasy? , 1984 .

[7]  D. Nelson,et al.  Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit. , 1988, Molecular pharmacology.

[8]  C. Hansch,et al.  A NEW SUBSTITUENT CONSTANT, PI, DERIVED FROM PARTITION COEFFICIENTS , 1964 .

[9]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[10]  C. Hansch,et al.  Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate. , 1985, Journal of medicinal chemistry.

[11]  A. Richter,et al.  Inhibition of human platelet 5‐hydroxytryptamine uptake by ß‐phenethylamine derivatives , 1974, The Journal of pharmacy and pharmacology.

[12]  A. Leo,et al.  Substituent constants for correlation analysis. , 1977, Journal of medicinal chemistry.

[13]  J. L. Fauchère.  QSAR: quantitative structure-activity relationships in drug design. Proceedings of the 7th European Symposium on QSAR. Interlaken, Switzerland, September 5-9, 1988. , 1989, Progress in clinical and biological research.

[14]  R. Glennon,et al.  Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane. , 1982, Journal of medicinal chemistry.

[15]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[16]  T. Högberg,et al.  Synthesis of pyridylallylamines related to zimelidine and their inhibition of neuronal monoamine uptake. , 1981, Journal of medicinal chemistry.

[17]  C. Hansch,et al.  Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate. , 1986, Cancer research.

[18]  P. Wood,et al.  Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines. , 1986, European journal of pharmacology.